Clinical Trials Browser

Phase 1 × Carcinoma, Non-Small-Cell Lung × MK 2206 × Clear all

NCT01147211 2013-05-03

Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC)

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung